Executive Vice President

ROBERT M. SHAW

** ********* **. • Sparta, New Jersey 07871 973-***-**** • ******.**@*****.***

Executive Summary:

An executive and attorney who has held senior-level business, operations, compliance, and legal positions

with international corporations; particular expertise in the pharmaceutical, biotech and chemical industries.

Entrepreneurial and results-focused; a take charge type with extensive experience in the development and

negotiation of profitable global business ventures.

A thorough and diligent business and legal strategist and decision-maker who knows what needs to be

done, does what needs to be done, and thrives in fast-paced, highly competitive markets.

Skilled in navigating through internal political issues and building consensus to achieve results.

Professional History:

K-V Pharmaceutical Company, May 2008 to present

Acting General Counsel / Vice President, Deputy General Counsel and Secretary

Member of the Executive Committee for this brand and generic, NYSE-listed pharmaceutical company with net

revenues of $600 million in 2008 and subsidiaries in England, Israel and the U.S. Initially hired to manage

litigation; became Acting General Counsel reporting to an interim CEO following a change in management.

Manages the Legal and Intellectual Property functions.

As Secretary, acts as legal advisor to the Board of Directors; also oversees SEC filings. Serves on the

Disclosure Committee.

Assures corporate compliance with laws and regulations. Serve s on the Compliance Committee. Provides

advice and counsel on corporate governance issues.

Interacts with the FDA, SEC and DOJ regarding various compliance issues and investigations.

Directs and conducts internal investigations.

Manages securities, ERISA, government pricing, products liability, commercial, patent and employee

litigation.

Pliva, Inc., Senior Vice President / General Counsel / Secretary, 2004 – 2008

Barr Pharmaceuticals, Consultant, Nov. 1, 2007 to May 2008

Member of the executive management team for the $480+ million U.S. subsidiary of a $1 billion global generic,

specialty pharmaceutical and API company with affiliates in Eastern and Western Europe.

Managed legal, intellectual property, corporate compliance, specialty pharmaceutical products, EHS (environmental,

health and safety), security and IT functions.

Drafted, implemented, and managed the corporate compliance program. Selected by the Board to investigate

allegations of impropriety; conducted internal investigations in the U.S., Croatia and Italy.

Consistently successful in dealing with the FDA to overcome concerns and secure approval of key products.

Provided executive oversight to the specialty pharmaceutical products business.

Managed commercial, employment, and patent litigation.

Negotiated and drafted complex transactions (including intellectual property licenses, product development, product

acquisition and divestiture and follow-on biologics) with U.S., European, Japanese and Indian entities.

Interacted with the FTC to resolve M&A issues.

Developed profitable strategy to introduce a generic equivalent of a multi-billion dollar antibiotic in the U.S.,

overcoming multiple obstacles, conflicts of interest and regulatory issues.

Decreased the average cost of goods and increased profits and competitiveness by negotiating agreements with

Indian companies to develop new products and manufacture existing products.

Note: Barr Pharmaceuticals acquired Pliva in late 2006. As the last remaining member of Pliva’s executive team, assisted Barr with the

transition and the shut down of Pliva’s U.S. operations, then served as a business and legal consultant to Barr and Pliva until May, 2008.

Robert M. Shaw -2-973-***-****

Savient Pharmaceuticals, Inc., East Brunswick, NJ, 1998 – 2004

Executive Vice President / Chief Administrative Officer / General Counsel / Secretary

Member of the four-person senior executive team for this publicly traded (NASDAQ) biotechnology, specialty

pharmaceutical company with subsidiaries in England, Israel and the U.S.

Managed the legal, intellectual property, regulatory, quality, corporate compliance, strategic planning, business

development, executive HR, and IT functions. Advised on SEC matters.

As Secretary and legal advisor to the Board, presided over annual shareholders’ meeting and was responsible for the

administration of the stock option plan and SEC filings.

Established, monitored and enforced corporate compliance policies.

Liaised with the House of Representatives and U.S. Senate on regulatory matters.

Successfully managed through a restatement following the collapse of Savient’s auditors, Arthur Andersen.

Together with the CFO, implemented Sarbanes-Oxley.

Structured and negotiated acquisitions, joint ventures, licenses, and other complex commercial transactions in the

U.S. and Europe. .

Managed securities, commercial, patent, intellectual property and employee-related litigation.

Negotiated two key acquisitions, Myelos Corporation and Rosemont Pharmaceuticals.

Managed Rosemont Pharmaceuticals (UK) post-acquisition for an interim period until a new management team

could be identified and installed.

BASF Corporation, Mt. Olive, NJ, 1989 – 1997

Vice President, Intellectual Property/Assistant Secretary (1993-1997)

Chief Patent Counsel/Assistant Secretary (1991-1993) Director, Patents (1989-1991)

Recruited to build and manage the Intellectual Property Department for this approx. $9 billion (U.S. sales)

manufacturer of chemicals, pharmaceuticals, fibers and other products. Hired and managed a 30+ member legal and

support team in six locations.

Managed all aspects of intellectual property portfolio issues, including litigation, licensing, acquiring and divesting

technology, obtaining patents and trademarks, and negotiating agreements.

Managed intellectual property litigation.

Served as lead negotiator on numerous complex commercial transactions in the U.S. and throughout Europe.

Served as counsel to BASF Bioresearch Corporation.

Developed and implemented cost containment agreements in litigations that resulted in substantial savings

without adversely impacting outcome.

Hoechst-Celanese Corporation, Chatham, NJ, 1984 – 1989

Associate General Counsel/Unit Manager/Assistant Secretary (1987-1989)

Group Patent Counsel (1986-1987) Senior Patent Attorney (1984-1986)

Originally retained as Patent Attorney; rapidly promoted to Associate General Counsel/Assistant Secretary for a

division of this $6 billion manufacturer of pharmaceuticals, chemicals, plastics and fibers.

Spearheaded business development and licensing projects, including acquisitions, divestitures, and strategic business

alliances with companies in the U.S., Europe and Japan.

Associate, Fish & Neave, New York, NY, 1981 – 1984

Associate, Synnestvedt & Lechner, Philadelphia, PA, 1979 – 1981

Robert M. Shaw -3-973-***-****

Education:

Juris Doctor, Washington University School of Law, St. Louis, MO (1979)

B.A. in Chemistry, cum laude, Amherst College, Amherst, MA (1976)

Bar Admissions:

Missouri (1979)

Pennsylvania (1980)

New York (1982)

New Jersey (2006 – 2008; in-house license)

U.S. Patent Office (1979 – Reg. No. 29,587)

District Courts: S.D.NY, E.D.NY, E.D.PA, W.D.MO

rd

Federal Courts of Appeal: 3 Cir., C.A.F.C.

Contact this candidate